Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 857, pseudogene (RNU6-857P)** is classified as a **pseudogene** related to U6 small nuclear RNA (snRNA), a component ordinarily involved in mRNA splicing as part of the spliceosome[2][6]. Pseudogenes such as RNU6-857P are typically non-functional copies of genes or non-coding RNA sequences and do not produce functional protein or RNA products[4]. This locus is annotated as a pseudogene on chromosome 18 and has no documented biological activity or disease involvement. Thus, RNU6-857P is not considered a therapeutic target, does not encode a functional receptor, enzyme, or other protein, and no drugs, mechanisms, or known biomarker roles are described[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 857, pseudogene (RNU6-857P).